J. P. Moody

932 total citations
26 papers, 717 citations indexed

About

J. P. Moody is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Pharmacology. According to data from OpenAlex, J. P. Moody has authored 26 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 8 papers in Biological Psychiatry and 5 papers in Pharmacology. Recurrent topics in J. P. Moody's work include Bipolar Disorder and Treatment (9 papers), Tryptophan and brain disorders (8 papers) and Treatment of Major Depression (5 papers). J. P. Moody is often cited by papers focused on Bipolar Disorder and Treatment (9 papers), Tryptophan and brain disorders (8 papers) and Treatment of Major Depression (5 papers). J. P. Moody collaborates with scholars based in United Kingdom, Australia and Canada. J. P. Moody's co-authors include G. J. Naylor, A. C. Tait, A Todrick, E. P. Worrall, H. Brian Mcnamee, Graham J. Naylor, Anna J. MacDonald, R. T. Williams, Malcolm Peet and R. T. Williams and has published in prestigious journals such as The Lancet, The British Journal of Psychiatry and Psychopharmacology.

In The Last Decade

J. P. Moody

25 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. P. Moody United Kingdom 16 359 193 114 111 81 26 717
T. A. Ban United States 15 276 0.8× 155 0.8× 128 1.1× 105 0.9× 27 0.3× 73 709
Peter H. Silverstone Canada 18 348 1.0× 223 1.2× 281 2.5× 182 1.6× 45 0.6× 30 912
G. J. Naylor United Kingdom 23 743 2.1× 231 1.2× 228 2.0× 274 2.5× 218 2.7× 61 1.4k
Burton J. Goldstein United States 14 233 0.6× 242 1.3× 198 1.7× 112 1.0× 15 0.2× 47 755
I Degrell Hungary 15 221 0.6× 71 0.4× 79 0.7× 92 0.8× 38 0.5× 36 734
Sidney S. Chang United States 11 460 1.3× 134 0.7× 66 0.6× 48 0.4× 24 0.3× 13 676
Bo Siwers Sweden 17 292 0.8× 256 1.3× 228 2.0× 192 1.7× 10 0.1× 23 865
Chester M. Davis United States 13 261 0.7× 118 0.6× 74 0.6× 98 0.9× 11 0.1× 17 735
K.W. Lieberman United States 13 154 0.4× 70 0.4× 103 0.9× 71 0.6× 19 0.2× 26 453
G. Laux Germany 10 292 0.8× 263 1.4× 63 0.6× 65 0.6× 15 0.2× 23 635

Countries citing papers authored by J. P. Moody

Since Specialization
Citations

This map shows the geographic impact of J. P. Moody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Moody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Moody more than expected).

Fields of papers citing papers by J. P. Moody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Moody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Moody. The network helps show where J. P. Moody may publish in the future.

Co-authorship network of co-authors of J. P. Moody

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Moody. A scholar is included among the top collaborators of J. P. Moody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Moody. J. P. Moody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moody, J. P.. (1999). Biologic Variation of Serum and Salivary Lithium. Therapeutic Drug Monitoring. 21(1). 97–101. 7 indexed citations
2.
Ho‐Yen, D O, et al.. (1982). Why smoke fewer cigarettes?. BMJ. 284(6333). 1905–1907. 20 indexed citations
3.
Moody, J. P., et al.. (1981). The effect of mianserin on urinary catecholamine excretion in psychiatric patients.. British Journal of Clinical Pharmacology. 11(1). 103–105. 1 indexed citations
4.
Worrall, E. P., J. P. Moody, Malcolm Peet, et al.. (1979). Controlled Studies of the Acute Antidepressant Effects of Lithium. The British Journal of Psychiatry. 135(3). 255–262. 72 indexed citations
5.
Moody, J. P., et al.. (1978). Attempt to demonstrate an in vivo effect of mianserin hydrochloride on erythrocyte Na+‐K+‐ATPase activity and cyclic AMP concentration.. British Journal of Clinical Pharmacology. 5(S1). 49S–51S. 3 indexed citations
6.
Moody, J. P., et al.. (1978). Placebo‐controlled double‐blind trial of mianserin hydrochloride.. British Journal of Clinical Pharmacology. 5(S1). 67S–70S. 36 indexed citations
7.
Hopwood, Sally, et al.. (1977). Age as a factor affecting lithium therapy.. British Journal of Clinical Pharmacology. 4(2). 201–205. 55 indexed citations
8.
Moody, J. P., et al.. (1977). Pharmacokinetic aspects of protriptyline plasma levels. European Journal of Clinical Pharmacology. 11(1). 51–56. 26 indexed citations
9.
Peet, Malcolm, et al.. (1976). Plasma Tryptophan Concentration in Depressive Illness and Mania. The British Journal of Psychiatry. 128(3). 255–258. 27 indexed citations
10.
Worrall, E. P., J. P. Moody, & Graham J. Naylor. (1975). Lithium in Non-Manic-Depressives: Antiaggressive Effect and Red Blood Cell Lithium Values. The British Journal of Psychiatry. 126(5). 464–468. 56 indexed citations
11.
Naylor, G. J., D. A. T. Dick, E. G. Dick, & J. P. Moody. (1974). Lithium therapy and erythrocyte membrane cation carrier. Psychopharmacology. 37(1). 81–86. 44 indexed citations
12.
Moody, J. P.. (1973). The Biological Availability of Clomipramine (Anafranil). Journal of International Medical Research. 1(5). 325–330. 3 indexed citations
13.
Mcnamee, H. Brian, J. P. Moody, & G. J. Naylor. (1972). Indoleamine metabolism in affective disorders: Excretion of tryptamine, indoleacetic acid and 5-hydroxyindoleacetic acid in depressive states. Journal of Psychosomatic Research. 16(1). 63–70. 8 indexed citations
14.
Naylor, G. J., H. Brian Mcnamee, & J. P. Moody. (1970). The plasma control of erythrocyte sodium and potassium metabolism in depressive illness. Journal of Psychosomatic Research. 14(2). 179–186. 10 indexed citations
15.
Naylor, G. J., et al.. (1970). Erythrocyte sodium and potassium in depressive illness. Journal of Psychosomatic Research. 14(2). 173–177. 26 indexed citations
16.
Moody, J. P., et al.. (1969). Circadian Rhythms of Water and Electrolyte Excretion in Manic-Depressive Psychosis. The British Journal of Psychiatry. 115(525). 923–928. 18 indexed citations
17.
Moody, J. P., A. C. Tait, & A Todrick. (1967). Plasma Levels of Imipramine and Desmethylimipramine during Therapy. The British Journal of Psychiatry. 113(495). 183–193. 116 indexed citations
18.
Moody, J. P. & R. T. Williams. (1964). The metabolism of 4-hydroxy-3-nitrophenylarsonic acid in hens. Food and Cosmetics Toxicology. 2. 707–715. 28 indexed citations
19.
McWeeny, David J., J. P. Moody, & H. Burton. (1964). The penetration by and distribution of calcium and bisulphite ions during potato scalding and hot‐air dehydration. Journal of the Science of Food and Agriculture. 15(4). 253–258. 4 indexed citations
20.
Brown, Anthony, J. P. Moody, & W. J. MERLE SCOTT. (1962). THE RHEUMATOID-ARTHRITIS TEST IN NON-RHEUMATOID CONDITIONS. The Lancet. 280(7268). 1276–1277. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026